parbendazole has been researched along with fosbretabulin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Du, L; Hu, M; Li, M; Liang, D; Ma, Z; Wang, J; Yu, C | 1 |
1 other study(ies) available for parbendazole and fosbretabulin
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of new parbendazole derivatives for the treatment of HNSCC.
Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Squamous Cell Carcinoma of Head and Neck | 2022 |